Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).
Sara M. Tolaney, MD, MPH
Advertisement
Articles by Sara M. Tolaney, MD, MPH
Advertisement
Latest Updated Articles
Dr. Sara M. Tolaney on Neoadjuvant Treatment Considerations for TNBCPublished: July 28th 2015 | Updated:
Advertisement
Advertisement
